Apollomics Inc. (APLM)
$26.60+$0.30 (+1.14%) Today
Hung-Wen Chen - OfficerHung-Wen Chen - OfficerHung-Wen Chen - OfficerPeter Kuan-How Lin - OfficerApollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 5 | 583,334 | $8.25M |
| Option exercise | 16 | 45,000 | |
| Tax withholding / forfeiture | 1 | 3,588 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
13 Form 4 filings on record, the earliest from Apr 17, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ya-Chi Huang - Director | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Ya-Chi Huang - Director | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Yi-Kuei Chen - Officer | Open-market purchase | CLASS A ORDINARY SHARES | 20,000 | $15.00 | $300K | |
| Peter Kuan-How Lin - Officer | Open-market purchase | CLASS A ORDINARY SHARES | 26,667 | $15.00 | $400K | |
| Hung-Wen Chen - Officer | Open-market purchase | CLASS A ORDINARY SHARES | 166,667 | $12.00 | $2.00M | |
| Hung-Wen Chen - Officer | Open-market purchase | CLASS A ORDINARY SHARES | 103,333 | $15.00 | $1.55M | |
| Hung-Wen Chen - Officer | Open-market purchase | CLASS A ORDINARY SHARES | 266,667 | $15.00 | $4.00M | |
| Peter Kuan-How Lin - Officer | Option exercise | CLASS A ORDINARY SHARES | 10,000 | $0.00 | - | |
| Peter Kuan-How Lin - Officer | Tax withholding / forfeiture | CLASS A ORDINARY SHARES | 3,588 | $13.85 | $50K | |
| Peter Kuan-How Lin - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - | |
| Hung-Wen Chen - Officer | Option exercise | Restricted Stock Units | 5,000 | $0.00 | - | |
| Hung-Wen Chen - Officer | Option exercise | CLASS A ORDINARY SHARES | 5,000 | $0.00 | - | |
| Yi-An Chu | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Yi-An Chu | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Hong-Jung Chen | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Hong-Jung Chen | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Hsien-Shu Tsai | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Hsien-Shu Tsai | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Yi-Kuei Chen - Officer | Option exercise | Restricted Stock Units | 5,000 | $0.00 | - | |
| Yi-Kuei Chen - Officer | Option exercise | CLASS A ORDINARY SHARES | 5,000 | $0.00 | - | |
| Chen-Huan Jan | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Chen-Huan Jan | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Ya-Chi Huang | Option exercise | CLASS A ORDINARY SHARES | 500 | $0.00 | - | |
| Ya-Chi Huang | Option exercise | Restricted Stock Units | 500 | $0.00 | - | |
| Peter Kuan-How Lin - Officer | Tax withholding / forfeiture | CLASS A ORDINARY SHARES | 3,582 | $15.85 | $57K |
Apollomics Inc. (APLM) had 11 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for APLM runs to 13 Form 4 filings, the earliest from 2026-04-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
5 insider purchases of APLM were filed in the last 90 days, totaling $8.25M.
No insider sales of APLM were filed in the last 90 days.
This page tracks APLM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add APLM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
